Sleep News and Research

Latest Sleep News and Research

Lilly's Axiron testosterone replacement therapy now available in US pharmacies

Eli Lilly and Company announced today that Axiron® (testosterone) topical solution is available in pharmacies throughout the United States. Axiron is a prescription medicine used to treat adult males that have low or no testosterone. Safety and efficacy of Axiron in males younger than 18 years of age have not been established.

1 Apr 2011

Nine state, local organizations to receive NHLBI grant for COPD education initiatives

Nine state and local organizations will receive a total of $383,000 for chronic obstructive pulmonary disease education initiatives, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, announced today.

1 Apr 2011

Study: Stress can increase risk of C section in first-time mothers

The risk of emergency caesarean section among first-time mothers increases if the mother has experienced stress, worry, or sleep disturbances during her pregnancy. This is shown in a unique study performed collaboratively between Malmö University, Skåne University Hospital, and Lund University in Sweden.

1 Apr 2011

New study examines psychological, social challenges of women with breast cancer

When an aggressive form of breast cancer strikes a young woman, what kind of stress, anxiety and other psychological and social challenges does she face?

1 Apr 2011

Study: Internet-based intervention can improve childhood sleep problems

A study in the April 1 issue of the journal SLEEP demonstrates that an Internet-based intervention was effective at reducing infant and toddler sleep disturbances, as well as providing positive, indirect benefits for maternal sleep, mood and confidence.

1 Apr 2011

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

A study in the April 1 issue of the journal SLEEP suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

1 Apr 2011

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Vanda Pharmaceuticals Inc. today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD). The trial is expected to begin during the second half of 2011. Tasimelteon is currently being evaluated in Phase III clinical trials for the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals without light perception.

31 Mar 2011

New Image to build dairy plant in New Zealand

Health and wellness products manufacturer New Image Group is to help meet global demand for more nutritional milk products with the building of a multi-million dollar, spray drying plant in New Zealand.

31 Mar 2011

Coro Health earns ALFA recognition for senior care programs

Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.

31 Mar 2011

Tips on neurobiology of learning

Everyone would like MDs to have the best education - and to absorb what they are taught. The lead article in the April 4 issue of the journal Academic Medicine connects research on how the brain learns to how to incorporate this understanding into real world education, particularly the education of doctors.

31 Mar 2011

Peregrine partners with WellAWARE to improve quality of care for seniors

WellAWARE Systems, the leading developer of next-generation wellness solutions for care providers, announced today that Peregrine Health Management Company will utilize WellAWARE to enhance the focus of delivering proactive and preventative care to its senior living residents.

31 Mar 2011

Study: Skills-training can enhance supportive responses to traumatic abuse disclosures

New research from the University of Oregon concludes that even brief training can help people learn how to be more supportive when friends and family members disclose traumatic events and other experiences of mistreatment.

30 Mar 2011

USPTO issues patent to Somaxon's Silenor food effect

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 7,915,307, entitled "Methods of Improving the Pharmacokinetics of Doxepin."

30 Mar 2011

Stress affects sleep, mood and body weight: Study

In a new study that appeared in the International Journal of Obesity, researchers have found that stress may affect sleep, mood and ultimately body weight. The study found that people with high stress and poor sleep were less likely to achieve a 10-lb. weight loss goal.

29 Mar 2011

Medical expert says PSTD cases may increase following Japanese tsunami

The Japanese tsunami took quite a massive toll, injuring and killing thousands and causing billions of dollars in destruction. But looking beyond physical destruction, the tsunami took an emotional toll on many as well.

29 Mar 2011

Study links sleep and stress levels to weight loss

If you want to increase your chances of losing weight, reduce your stress level and get adequate sleep. A new Kaiser Permanente study found that people trying to lose at least 10 pounds were more likely to reach that goal if they had lower stress levels and slept more than six hours but not more than eight hours a night.

29 Mar 2011

Study highlights tobacco smoke exposure among babies

"Passive smoking is the leading preventable cause of childhood death in developed countries", Guadalupe Ortega, lead author of the research study and coordinator of the Atenció Primària Sense Fum programme at the Department of Health of the Generalitat de Cataluña tells SINC.

29 Mar 2011

IDF: Obese people with type 2 diabetes can benefit from bariatric surgery

Bariatric surgery should be considered earlier in the treatment of eligible patients to help stem the serious complications that can result from diabetes, according to an International Diabetes Federation position statement presented by leading experts at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes in New York.

29 Mar 2011

Dementia & Alzheimer’s drug trial with sleep hormone melatonin

A new drug is in the making that could improve the quality of life for people with dementia. Glasgow-based medical research company CPS Research is conducting a clinical trial using a drug containing the sleep hormone melatonin, which it is hoped will reduce the symptoms associated with the illness.

28 Mar 2011

From fatigued to fantastic! You CAN effectively treat CFS, fatigue, fibromyalgia and muscle pain

The “perfect storm” for Fibromyalgia, CFS/ME, and fatigue in general is preparing to hit. A combination of poor nutrition, decreasing sleep, increasing stress and environmental toxins has created a human energy crisis of unprecedented proportions. Over the past 10 years, the incidence of Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS) has exploded by 400 to 1000 percent, as documented in five separate studies. The numbers for those with CFS in the U.S., previously estimated at 500,000, are now being re-tallied at closer to 1- 2.5 million. Previous estimates placed the number of Americans with FMS at 6 million. Studies worldwide suggest this has likely gone up in the last decade to ~ 12-24 million Americans! Meanwhile, ¼ of Americans suffer with chronic pain and most are fatigued.

28 Mar 2011